What does DR. SOFIE DEPUYDT, HEELKUNDE do?

DR. SOFIE DEPUYDT, HEELKUNDE is a specialist medical practice in Oostende. Private Limited, started on 1 April 2015, 1 establishment.

What is the address of DR. SOFIE DEPUYDT, HEELKUNDE?

The registered office of DR. SOFIE DEPUYDT, HEELKUNDE is located at Gistelsesteenweg 254, 8400 Oostende.

Is DR. SOFIE DEPUYDT, HEELKUNDE still active?

Yes. According to the CBE (30 September 2026) DR. SOFIE DEPUYDT, HEELKUNDE is active, legal situation “Normale toestand”, started on 1 April 2015.

Is DR. SOFIE DEPUYDT, HEELKUNDE registered on Peppol?

Yes, DR. SOFIE DEPUYDT, HEELKUNDE is registered on the Peppol network with ID 0208:0627818939.

What is the enterprise number of DR. SOFIE DEPUYDT, HEELKUNDE?

The enterprise number of DR. SOFIE DEPUYDT, HEELKUNDE is BE0627818939.

When was DR. SOFIE DEPUYDT, HEELKUNDE founded?

DR. SOFIE DEPUYDT, HEELKUNDE was founded on 1 April 2015.

Who are the directors of DR. SOFIE DEPUYDT, HEELKUNDE?

According to the 2025 annual accounts, the directors of DR. SOFIE DEPUYDT, HEELKUNDE are: Sofie Depuydt.

Is DR. SOFIE DEPUYDT, HEELKUNDE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 April 2015; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. SOFIE DEPUYDT, HEELKUNDE make in 2025?

DR. SOFIE DEPUYDT, HEELKUNDE posted a profit after taxes of € 196,405 in financial year 2025.

What is the revenue of DR. SOFIE DEPUYDT, HEELKUNDE?

As a small company, DR. SOFIE DEPUYDT, HEELKUNDE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 285,441.

DR. SOFIE DEPUYDT, HEELKUNDE (Private Limited) - Oostende

Dossier DR. SOFIE DEPUYDT, HEELKUNDE, printed on 30 September 2026 from databakkes.be/en/0627818939/dr-sofie-depuydt-heelkunde. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 63 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

DR. SOFIE DEPUYDT, HEELKUNDE from Oostende, company number BE0627818939, closed financial year 2025 with a result of € 196,405 after tax. For that financial year DR. SOFIE DEPUYDT, HEELKUNDE recorded a gross margin of € 285,441 and equity of € 275,415. Compared with financial year 2024, the result moved from € 148,704 to € 196,405. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.

What it is worth Healthy

€ 275,415

▼ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 196,405

▲ 32% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 43,206

▼ 56% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 200,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 22,588

▼ 35% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 21,940

▼ 35% vs 2024

€ 12,343 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 1,264

▼ 24% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,298

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 273,005 Gross margin 2022: € 273,005 First fiscal year in the series	€ 282,938 Gross margin 2023: € 282,938 ▲ 4% vs 2022 (€ 273,005) Favourable step	€ 267,427 Gross margin 2024: € 267,427 ▼ 5% vs 2023 (€ 282,938) Unfavourable step	€ 285,441 Gross margin 2025: € 285,441 ▲ 7% vs 2024 (€ 267,427) Favourable step	▲ 7%
Profit after taxes	€ 160,135 Profit after taxes 2022: € 160,135 First fiscal year in the series	€ 156,761 Profit after taxes 2023: € 156,761 ▼ 2% vs 2022 (€ 160,135) Unfavourable step	€ 148,704 Profit after taxes 2024: € 148,704 ▼ 5% vs 2023 (€ 156,761) Unfavourable step	€ 196,405 Profit after taxes 2025: € 196,405 ▲ 32% vs 2024 (€ 148,704) Favourable step	▲ 32%
Equity	€ 323,545 Equity 2022: € 323,545 First fiscal year in the series	€ 330,306 Equity 2023: € 330,306 ▲ 2% vs 2022 (€ 323,545) Favourable step	€ 279,010 Equity 2024: € 279,010 ▼ 16% vs 2023 (€ 330,306) Unfavourable step	€ 275,415 Equity 2025: € 275,415 ▼ 1% vs 2024 (€ 279,010) Unfavourable step	▼ 1%
Total debts	€ 213,988 Total debts 2022: € 213,988 First fiscal year in the series	€ 206,748 Total debts 2023: € 206,748 ▼ 3% vs 2022 (€ 213,988) Favourable step	€ 242,004 Total debts 2024: € 242,004 ▲ 17% vs 2023 (€ 206,748) Unfavourable step	€ 232,021 Total debts 2025: € 232,021 ▼ 4% vs 2024 (€ 242,004) Favourable step	▼ 4%
Cash	€ 211,242 Cash 2022: € 211,242 First fiscal year in the series	€ 259,372 Cash 2023: € 259,372 ▲ 23% vs 2022 (€ 211,242) Favourable step	€ 97,986 Cash 2024: € 97,986 ▼ 62% vs 2023 (€ 259,372) Unfavourable step	€ 43,206 Cash 2025: € 43,206 ▼ 56% vs 2024 (€ 97,986) Unfavourable step	▼ 56%
Retained profit	€ 304,945 Retained profit 2022: € 304,945 First fiscal year in the series	€ 311,706 Retained profit 2023: € 311,706 ▲ 2% vs 2022 (€ 304,945) Favourable step	€ 260,410 Retained profit 2024: € 260,410 ▼ 16% vs 2023 (€ 311,706) Unfavourable step	€ 256,815 Retained profit 2025: € 256,815 ▼ 1% vs 2024 (€ 260,410) Unfavourable step	▼ 1%
Dividend	€ 150,000 Dividend 2022: € 150,000 First fiscal year in the series	€ 150,000 Dividend 2023: € 150,000 Unchanged (€ 150,000) Unchanged	€ 200,000 Dividend 2024: € 200,000 ▲ 33% vs 2023 (€ 150,000) Unchanged	€ 200,000 Dividend 2025: € 200,000 Unchanged (€ 200,000) Unchanged
Bank debt	€ 56,052 Bank debt 2022: € 56,052 First fiscal year in the series	€ 45,145 Bank debt 2023: € 45,145 ▼ 19% vs 2022 (€ 56,052) Favourable step	€ 33,784 Bank debt 2024: € 33,784 ▼ 25% vs 2023 (€ 45,145) Favourable step	€ 21,940 Bank debt 2025: € 21,940 ▼ 35% vs 2024 (€ 33,784) Favourable step	▼ 35%
Balance sheet total	€ 537,533 Balance sheet total 2022: € 537,533 First fiscal year in the series	€ 537,055 Balance sheet total 2023: € 537,055 Unchanged (€ 537,533) Unchanged	€ 521,014 Balance sheet total 2024: € 521,014 ▼ 3% vs 2023 (€ 537,055) Unchanged	€ 507,436 Balance sheet total 2025: € 507,436 ▼ 3% vs 2024 (€ 521,014) Unchanged	▼ 3%

Key figures of DR. SOFIE DEPUYDT, HEELKUNDE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. SOFIE DEPUYDT, HEELKUNDE?

What happened at DR. SOFIE DEPUYDT, HEELKUNDE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 31, 2026 New annual accounts for financial year 2025: profit of € 196,405 (▲ 32% vs 2024). Source: NBB ↗
Apr 1, 2015 New establishment in Oostende. KBO
Apr 1, 2015 Start of the company according to the CBE. KBO

In short

From € 160,135 profit in 2022 to € 196,405 profit in 2025.

Paid € 210,822 in corporate taxes since 2022.

Best year ever: 2025, with € 196,405 profit.

Paid out € 700,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. SOFIE DEPUYDT, HEELKUNDE? We notify you, reason included.

Follow DR. SOFIE DEPUYDT, HEELKUNDE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Sofie Depuydt

DR. SOFIE DEPUYDT, HEELKUNDE

Behind DR. SOFIE DEPUYDT, HEELKUNDE is Sofie Depuydt.

See the full network in the app

Directors

According to the 2025 annual accounts

Sofie Depuydt

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Gistelsesteenweg 254

8400 Oostende

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0627.818.939
VAT number: BE 0627.818.939
Registered office: Gistelsesteenweg 254, 8400 Oostende
Names & denominations: DR. SOFIE DEPUYDT, HEELKUNDE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 1 April 2015
Peppol: Active · Active since 17 Nov 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗